Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02174315 · ClinicalTrials.gov registry record · NA
Motivational Incentives for Alcohol Abstinence in American Indian and Native Alaskan Adults
A NA study of Alcohol Abuse, sponsored by Washington State University.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT02174315: Completed NA study of Alcohol Abuse, sponsored by Washington State University.
NCT02174315 is a NA study of Alcohol Abuse that has completed, run by Washington State University. The registered enrollment target is 400 participants, below the 704-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (43% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02174315, a NA study of Alcohol Abuse, has completed, sponsored by Washington State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study examines the impact of a culturally tailored version of contingency management treatment on alcohol in 400 alcohol dependent American Indians and Alaskan Natives. Participants will be recruited from addiction treatment agencies and throughout the community. Those who complete a 4 week induction period will be randomized to receive 12 weeks of contingency management or a non-contingent control condition. Individuals will then be followed for an additional 3-months to assess the long term efficacy of the treatment.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management
Study Locations (1)
Washington
- Contact PI - Pullman
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2014-10-01 |
| Est. Completion | 2019-09-09 |
| Phase | NA |
What the finished NCT02174315 record still lists
NCT02174315 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 704-participant average among 46 other Alcohol Abuse trials with a reported enrollment target (43% lower).
The record links to 1 condition, with Alcohol Abuse appearing as the primary indexed condition, and to 1 intervention - of which Contingency Management is the first listed.
NCT02174315 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT02174315 about?
NCT02174315 is a clinical study titled "Motivational Incentives for Alcohol Abstinence in American Indian and Native Alaskan Adults". This study examines the impact of a culturally tailored version of contingency management treatment on alcohol in 400 alcohol dependent American Indians and Alaskan Natives. Participants will be recruited from addiction treatment agencies and throughout the community. Those who complete a 4 week ind...
What is the current status of trial NCT02174315?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2014-10-01. Estimated completion is 2019-09-09.
What conditions does trial NCT02174315 study?
This clinical trial studies the following conditions: Alcohol Abuse.
What interventions are being tested in trial NCT02174315?
The interventions under investigation include: Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02174315?
This trial is sponsored by Washington State University, which has 64 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02174315 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02174315's enrollment target sits among peer trials
400 11th of 46 higher than 35 of 46 other Alcohol Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Personalized Feedback Intervention for Latinx Drinkers With Anxiety
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Mobile App for Latinx Hazardous Drinkers With Clinical Anxiety
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Safety and Effectiveness of the BrainsWay Deep Transcranial Magnetic Stimulation (Deep TMS) for Treatment of Alcohol Use Disorder (AUD)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI